|
HS Code |
624756 |
| Generic Name | Maropitant Citrate |
| Brand Names | Cerenia |
| Drug Class | Neurokinin-1 (NK1) receptor antagonist |
| Formulation | Tablets, Injectable Solution |
| Route Of Administration | Oral, Subcutaneous Injection |
| Primary Use | Prevention and treatment of vomiting in dogs and cats |
| Species | Dogs, Cats |
| Mechanism Of Action | Inhibits substance P in the central nervous system |
| Prescription Status | Prescription Only |
| Storage Conditions | Store below 30°C (86°F), protect from moisture |
| Common Side Effects | Pain at injection site, drowsiness, diarrhea |
| Approved Age Group | Dogs: 8 weeks and older; Cats: 16 weeks and older |
| Metabolism | Extensively metabolized in the liver |
| Half Life | Approximately 6 hours in dogs (varies by species) |
| Contraindications | Known hypersensitivity to maropitant citrate |
As an accredited Maropitant Citrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a white, 20 mL glass vial with a blue cap, labeled "Maropitant Citrate Injection 10 mg/mL." |
| Shipping | Maropitant Citrate is shipped in tightly sealed, clearly labeled containers to prevent contamination and moisture exposure. It is transported under ambient conditions, avoiding extreme temperatures. All packages comply with applicable safety, handling, and regulatory guidelines for pharmaceuticals. Accompanying documentation ensures traceability and safe delivery to the designated address. |
| Storage | Maropitant citrate should be stored at controlled room temperature, generally between 20°C to 25°C (68°F to 77°F). Protect it from light and moisture by keeping it in its original, tightly closed container. Avoid freezing or exposing the solution to excessive heat. Ensure the storage area is secure and inaccessible to unauthorized personnel, pets, and children. |
|
Purity 99%: Maropitant Citrate with 99% purity is used in veterinary antiemetic formulations, where high purity enhances efficacy in controlling nausea and vomiting. Stability temperature 25°C: Maropitant Citrate with a stability temperature of 25°C is used in oral suspension preparations, where product integrity is maintained under standard storage conditions. Molecular weight 531.1 g/mol: Maropitant Citrate with a molecular weight of 531.1 g/mol is used in injectable dosage forms, where optimal dosing precision is achieved for clinical applications. Particle size D90 < 20 µm: Maropitant Citrate with particle size D90 less than 20 µm is used in tablet manufacturing, where fine particle distribution promotes uniform content and dissolution. Solubility in water 15 mg/mL: Maropitant Citrate with water solubility of 15 mg/mL is used in liquid veterinary medications, where high solubility enables rapid onset of action. Melting point 140°C: Maropitant Citrate with a melting point of 140°C is used in solid dosage formulations, where thermal stability during processing ensures consistent product performance. |
Competitive Maropitant Citrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Those who care for animals, either as veterinarians or as pet owners, eventually run into a battle against nausea and vomiting. Dogs and cats can suffer distress, dehydration, and nutrient loss when these symptoms are not brought under control. Maropitant Citrate steps in as a reliable, targeted treatment in clinics around the world. This compound isn’t just one more bottle on the pharmacy shelf—it reflects years of research and the tireless push to provide better care for animals who can't always tell us what’s wrong.
Maropitant Citrate shows up most often as tablets and injectables, each offered in several strengths to let veterinarians tailor doses to a patient’s weight and condition. Tablets suit home care for dogs with ongoing issues such as motion sickness or chemotherapy-induced nausea, while the injectable form often finds its place in the clinic, especially ahead of anesthesia or for severe cases where quick action matters.
Handling doesn’t ask for any complicated equipment—just the right storage and straightforward dosing that can be handled by any technician or pet owner with basic instruction. Precision becomes possible thanks to the range of tablet sizes and syringes with marking, which means nobody has to “eyeball” a dose or worry about tricky measurements.
Each format avoids the artificial dyes and unnecessary fillers often found in generics. Taste-masking technology, especially in the tablets, makes life easier for dogs: I’ve seen many dogs that spat out older, chalky medication, but most will accept Maropitant Citrate tablets without suspicion—which means less wrestling and fewer missed doses.
Maropitant Citrate acts by blocking neurokinin-1 (NK1) receptors in the brain. This targets a specific area called the chemoreceptor trigger zone. The technical explanation boils down to this: instead of just calming the stomach like older drugs, Maropitant blocks the pathway the body uses to make animals feel sick and throw up. Since it sidesteps the drowsiness and appetite loss linked to antihistamines and phenothiazines, dogs and cats can stay alert and eager to eat—a clear step forward for pets with chronic illness or animals recovering from surgery.
My experience in a mixed animal practice left me convinced this approach offers a real leap forward. Animals suffering from parvovirus, pancreatitis, or after a tough transport bounced back faster and felt comfortable sooner. I saw puppies eager for food the next morning and older arthritic dogs bouncing onto their feet again. That’s the kind of change everyone—vet, pet, and owner—can appreciate.
A fair comparison always starts with what came before. Before Maropitant Citrate, veterinary teams relied on metoclopramide, chlorpromazine, and ondansetron. Each had limits. Metoclopramide, for instance, only helped certain types of nausea and sometimes caused jitteriness, restlessness, or even tremors. Chlorpromazine could leave dogs wobbly and dehydrated, which is the opposite of what sick animals need. Ondansetron works but drove up costs, especially for larger animals or extended courses.
Maropitant Citrate stands out for its broad activity. It controls vomiting tied to motion, toxins, drugs, and disease—without artificial “quieting” or mental fog. By focusing only on the vomiting center, there’s no “haze” left behind, which matters for working dogs or animals in the home who need to stay alert. Unlike some alternatives, Maropitant does not depress breathing, and it lacks the bitter taste that used to derail treatment plans.
A further advantage: Maropitant works across both dogs and cats, whereas options like metoclopramide and ondansetron can produce unpredictable results from one species to the next. So, practices with both dogs and cats find Maropitant Citrate a convenient stocking choice—nurses and doctors grow familiar with protocols and don't need to second guess whether it's the right call for a particular breed or age.
The confidence in Maropitant Citrate isn't just word-of-mouth. Peer-reviewed studies, like those published in the Journal of Veterinary Internal Medicine and Veterinary Anaesthesia and Analgesia, have measured its real-world results. In a multicenter trial, a single dose curbed vomiting in more than 90% of dogs given chemotherapy—a rate unmatched by earlier options. For canine motion sickness, Maropitant brought travel-related drooling and retching below 10%, while untreated control groups still showed distress in 70% of cases.
Adverse effects, in my own caseload and in published studies, rarely pose an issue unless a dog or cat carries a specific liver abnormality. That’s why basic bloodwork and awareness of drug interactions remain a smart part of prescribing. Otherwise, injection site pain—transient and mild—sometimes crops up. Most patients act entirely normal within minutes after dosing. Big clinics have confirmed this, and I’ve watched even the timidest puppies endure a shot with only a slight whimper.
Pharmacovigilance records from Europe and North America count allergic reactions as exceedingly rare. Owners notice improved energy and appetite, not drugged sluggishness—a tradeoff nearly everyone would choose.
Few things worry owners as much as a pet that won’t keep down food or water. For dogs who need cancer treatment, cats with kidney failure, and animals facing a long recovery, the stress compounds fast. Pet parents miss work, worry about messes, and sometimes start doubting whether the treatment is worth it.
Maropitant Citrate’s reliability soothes this anxiety. Owners report less frequent visits to the vet just to replace lost fluids. They no longer juggle towels and bland diets, or wrangle their animals into crates every few days. It empowers people to stay the course with treatments their vets recommend—antibiotics, chemotherapy, innovative diets—because keeping medication down becomes a solvable problem, not a constant roadblock.
It matters for shelter medicine, too. Foster caregivers faced with vomiting puppies often lose hope or run out of options before the animals ever find a new home. Maropitant Citrate helps these vulnerable animals regain strength, move up for adoption, and avoid wasting valuable kennel space battling fluid loss or poor weight gain. I’ve watched shelters trim down quarantine times and see more sick animals regain adoption-eligible health status, all thanks to this single, targeted intervention.
No solution covers every base. The higher cost compared to old-fashioned medications limits access in underfunded clinics or rescue settings. Some rural patients still turn to metoclopramide or ginger because pennies matter more than pharmacology in their corner of the world. Some insurance plans slow to update formularies may not yet reimburse for Maropitant Citrate outside chemotherapy or severe illness.
Experience tells me this isn’t a reason for despair, but a call for broader distribution and honest talks with suppliers and manufacturers. Larger-volume packaging would bring prices down and make daily use practical even in animal shelters. Community education—led by techs and vets familiar with the drug—could chip away at old habits and open possibilities for sliding-scale support. Manufacturers who work with veterinary outreach programs, or offer surplus stock for hard-hit regions, will help bridge the current gap between the top-tier clinics and the average rescue or foster home.
The injectable version deserves greater innovation, too. Some animals—especially older cats—react to the sting with distrust or outright aggression. Still, most tolerate oral dosing well, so an even more palatable tablet, a flavored paste, or a dissolvable strip could bring this drug into more homes and make stressful trips to the clinic less frequent.
More research will push the science even further. While Maropitant already works for a range of vomiting causes, studies could further explore its effects against other forms of gut distress, or open up veterinary use in smaller exotic mammals where nausea also wrecks a creature’s ability to heal. Pet owners with birds, rabbits, or reptiles need options just as much, and the future could see this once-narrow tool become a solution for a broader range of creatures.
Maropitant Citrate shines especially bright in settings that prize medical precision. For example, in an emergency clinic, the time saved by skipping extra anti-nausea injections lets staff focus on breathing crises, infections, or surgeries—staff and patients both benefit. In mixed-animal practices, it prevents the need to stock half a dozen less effective drugs, clearing up both shelf space and confusion among new hires.
Veterinary nurses value it for the peace of mind. I’ve talked to countless colleagues who describe a clinic day before and after the widespread adoption of Maropitant. Gone are the days of hour-long rehydration or guessing games with unresponsive pets. There are fewer frantic calls from owners about dogs refusing pills, and more conversations about progress, appetite, and comfort. This shift frees up clinical energy to tackle the root problems—tumors, toxins, pain—without constantly fighting off the side effects of nausea medicines themselves.
Though Maropitant Citrate already brings relief to millions of animals each year, there’s still plenty of ground to cover. Expanding access depends on collaborative efforts across manufacturers, distributors, veterinarians, and advocacy groups. Lessons from human medicine suggest price drops follow patent expiry and expanded generic production, and there are signs the same may occur here.
Education remains crucial. Even now, some practitioners skip straight to fluids or dietary changes, not realizing Maropitant offers a straightforward fix without dangerous sedative effects. Veterinary schools and tech programs need to update protocols in textbooks and curricula, so new graduates recognize its place—and its limitations—right from the start.
Community education, too, can shift the narrative. Rescue workers, foster families, and savvy pet owners who understand this drug’s safety profile and proven benefits can speak up at clinics, opening doors for their animals to receive updated treatment. Social media groups and local veterinarians teaming up for webinars or information nights could get the message out much faster than flyers in a waiting room.
Cultural shifts can be slow, but animal health trends move quickly thanks to love and advocacy. Maropitant Citrate stands as an example of medical progress that makes a visible, tangible difference—reaching beyond sterile statistics to safeguard thousands of mealtimes, let animals recover with comfort, and restore peace to the worried minds of all those who care for a sick pet. It’s in these small, hard-won victories where real improvement in animal welfare takes root.
Among veterinary care options, Maropitant Citrate carved out a unique and necessary role. Safe for use in dogs and cats of all life stages, it means fewer clinic visits, more restful nights, and real hope for both simple cases of car sickness and the stubborn, life-threatening bouts of disease-related vomiting. Consistent performance, supportive research, wide tolerability, and species-crossing activity separate it from the half-solutions that came before.
I’ve been in enough exam rooms to know that health care decisions aren’t just about what works on paper—they reflect budgets, personalities, clinic cultures, and emotional strain. Maropitant Citrate responds to these human realities as much as to illness itself. Animals trust with their eyes and their tails, not their words, and keeping them eating, drinking, and alert shortens the road home for everyone involved. Innovations like this shine longest when producers, clinics, and pet owners match technological progress with compassion, education, and broader access.
In years to come, the story of Maropitant Citrate’s adoption across small towns, shelters, and big city hospitals will continue to reflect broader trends in veterinary medicine: solutions that value not only scientific merit but also the lived experience of animals and the people alongside them. Each dose means fewer setbacks and more shared meals, and sometimes, that makes all the difference.